Clinical Trial Detail

NCT ID NCT03241745
Title A Study of Nivolumab in Selected Uterine Cancer Patients
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

endometrial carcinoma

fallopian tube carcinosarcoma

endometrial stromal sarcoma

uterus leiomyosarcoma

ovarian carcinosarcoma

uterine cancer

uterine carcinosarcoma

Therapies

Nivolumab

Age Groups: adult senior

No variant requirements are available.